These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 22626795
1. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Sharma P, Sharma BC. Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795 [Abstract] [Full Text] [Related]
3. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction. El-Karaksy HM, Afifi O, Bakry A, Kader AA, Saber N. World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780 [Abstract] [Full Text] [Related]
4. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. Sharma P, Sharma BC, Agrawal A, Sarin SK. J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978 [Abstract] [Full Text] [Related]
5. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Agrawal A, Sharma BC, Sharma P, Sarin SK. Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579 [Abstract] [Full Text] [Related]
6. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Sharma P, Sharma BC, Sarin SK. Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401 [Abstract] [Full Text] [Related]
8. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Singh J, Sharma BC, Puri V, Sachdeva S, Srivastava S. Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704 [Abstract] [Full Text] [Related]
9. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Sharma P, Kumar A, Singh S, Tyagi P, Kumar A. Saudi J Gastroenterol; 2013 Apr; 19(1):40-4. PubMed ID: 23319037 [Abstract] [Full Text] [Related]
14. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction. Yadav SK, Goel A, Saraswat VA, Thomas MA, Wang E, Marincola FM, Haris M, Gupta RK. J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420 [Abstract] [Full Text] [Related]
18. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial. Schulz C, Schütte K, Kropf S, Schmitt FC, Vasapolli R, Kliegis LM, Riegger A, Malfertheiner P. Trials; 2016 Feb 29; 17(1):111. PubMed ID: 26926775 [Abstract] [Full Text] [Related]
19. Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. Sharma P, Kumar A. Saudi J Gastroenterol; 2012 Feb 29; 18(5):316-21. PubMed ID: 23006459 [Abstract] [Full Text] [Related]